T h e r a p e u t i c I n d e x 66 Evecare forte® (liquid, tablet) For the effective management of PCOS Composition Each 5 mL of Evecare forte liquid contains Exts. Lodhra (Symplocos racemosa)..........................41.25 mg Methi (Trigonella foenum-graecum). .............40.22 mg Mundi (Sphaeranthus indicus). ........................18.57 mg Jatamansi (Nardostachys jatamansi)............... 8.59 mg Pdr. Kanyasaara (Aloe barbadensis). ......................... 3.87 mg Each Evecare forte tablet contains: Exts. Lodhra (Symplocos racemosa)............................. 165 mg Methi (Trigonella foenum-graecum). .......... 160.89 mg Mundi (Sphaeranthus indicus). ........................74.26 mg Jatamansi (Nardostachys jatamansi).............34.38 mg Pdr. Kanyasaara (Aloe barbadensis). .......................15.47 mg Clinical Pharmacology Evecare forte is a safe, phytopharmaceutical, nonhormonal menstrual modulator. Evecare forte helps regularize endogenous hormonal status, correct the cyclical rhythm, and reduce the number of abnormal follicles. Evecare forte improves ovulatory function and other metabolic derangements associated with insulin resistance (IR) through its insulin-sensitizing activity. Evecare forte also alleviates the symptoms of PCOS, including hirsutism, hyperpigmentation, mood swings, anxiety, and depression and improves fertility. Indication PCOS Dosage Liquid: 10 to 20 mL twice daily, for 3 to 6 months. Tablet: 1 tablet twice daily. Adverse Effects No adverse effects have been reported. Evecare forte is a phytopharmaceutical formulation recommended for the effective and comprehensive management of polycystic ovarian syndrome (PCOS).
RkJQdWJsaXNoZXIy MjMwNjM2Nw==